FINDINGS:
Comparison: 2023-05-11.
Pulmonary parenchyma: No focal consolidation or suspicious pulmonary nodules. No pneumothorax.
Mediastinum: Enlarged paratracheal lymph node, short axis 10 mm with central necrosis. Cardiomediastinal contours within normal limits.
Pleura/Pleural spaces: No pleural effusion or pleural thickening.
Great vessels/Aorta: No thoracic aortic aneurysm or dissection. aorta normal caliber.
Liver: 29 mm irregular hepatic mass in segment 2 of the liver (isoenhancing). No focal hepatic lesions. Normal attenuation.
Spleen: Normal in size and attenuation. No focal splenic lesion.
Pancreas: Normal pancreatic contour and enhancement. No focal mass.
Adrenal glands: Adrenal glands are normal without nodules. no adrenal nodule.
Kidneys: No hydronephrosis. No enhancing renal mass. no renal mass.
GI tract/Bowel: No obstructive process. No focal bowel wall mass identified.
Mesentery/Omentum: 0.5 cm lesion in the peritoneum, suspicious for metastasis. No ascites. No omental caking. no peritoneal nodularity.
Mesenteric vessels (SMA/SMV): SMA/SMV are patent without thrombosis.
Urinary bladder: Unremarkable.
Reproductive organs: No adnexal mass. Uterus/prostate within expected size for age. prostate is normal / no prostatic mass.
Lymph nodes: Enlarged internal iliac lymph node, short axis 11 mm. No pathologically enlarged lymph nodes by size criteria.
Bones/Osseous structures: 14 mm lesion in the bone, suspicious for metastasis. No aggressive osseous lesion. No acute fracture.

IMPRESSION:
- Liver primary malignancy at segment 2 of the liver measuring approximately 29 mm.
- Findings concerning for nodal involvement.
- Findings compatible with distant metastases involving: bone, peritoneum.
- RECIST 1.1 Summary:
- Target lesions (n=4; ≤2 per organ rule applied).
  • T1: Primary — 54→29 mm (longest diameter).
  • T2: Metastasis — 25→14 mm (longest diameter).
  • T3: Metastasis — 10→5 mm (longest diameter).
  • T4: Lymph node — 20→11 mm (short axis).
- SLD baseline: 109 mm.
- SLD current: 59 mm (-45.9% change).
- New lesions: absent (unequivocal).
- - RECIST 1.1 overall response category: PR.
